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OBJECTIVES: To determine how development of delir-
ium after surgical aortic valve replacement (SAVR) or
transcatheter aortic valve implantation (TAVI) could pre-
dict activity of daily living (ADL) and instrumental ADLs
(IADL) disability, cognitive function, and self-reported
health in individuals aged 80 and older.
DESIGN: Prospective cohort study.
SETTING: Tertiary university hospital.
PARTICIPANTS: Individuals aged 80 and older undergo-
ing elective SAVR or TAVI (N = 136).
MEASUREMENTS: Delirium was assessed for 5 days
using the Confusion Assessment Method. The Barthel
Index, Nottingham Extended ADL Scale, and SF-12 were
used to determine ADL and IADL ability and self-reported
health at baseline and 1- and 6-month follow-up. Cogni-
tion was assessed using the Mini-Mental State Examina-
tion at baseline and 6-month follow-up.
RESULTS: Participants had lower IADL scores 1 month
after SAVR than at baseline (baseline 58, 1 month: delirium
42, no delirium 50, P ≤ .02), but scores had returned to
baseline levels at 6 months. The Medical Outcomes Study
12-item Short-Form Health Survey (SF-12) Physical Compo-
nent Summary (PCS) score was higher at 6-month follow-up
(48) than at baseline (39), especially in participants who did
not develop delirium (P < .001). No differences in other
outcomes were found. Regression models suggest that delir-
ium may help predict IADL disability 1 month after baseline
(P ≤ .07) but does not predict large differences in ADL dis-
ability, cognitive function, or SF-12-scores. Individuals who
underwent TAVI and developed delirium had lower ADL
(baseline 19, 1-month 16, P < .001) and IADL (baseline 49,
1-month 40, P = .003) scores at 1-month follow-up. SF-12
PCS score (baseline 30) increased from baseline to 1- (35,
P = .04) and 6- (35, P = .02) month follow-up in individu-
als who underwent TAVI and did not develop delirium.
Delirium after TAVI predicted greater ADL and IADL dis-
ability at 1-month but not at 6-month follow-up.
CONCLUSION: Individuals who develop delirium after
SAVR and TAVI have poorer short-term IADL function
but do not seem to have long-term reductions in physical,
mental, or self-reported health. J Am Geriatr Soc 64:1178–
1186, 2016.
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A high incidence of delirium occurs in elderly adultsundergoing cardiac surgery.1–3 The prevalence of aor-
tic stenosis is greater in elderly adults than in the general
population.4 Even though symptomatic aortic stenosis has
high mortality when untreated,5 the risk of performing
surgical aortic valve replacement (SAVR) might be too
high in frail elderly adults with several comorbidities.6
Transcatheter aortic valve implantation (TAVI) is an
option for individuals for whom SAVR is unsuitable.6,7
Functional and cognitive decline have been reported in
individuals experiencing delirium after hip fracture8 and car-
diac surgery.9–11 For aortic stenosis, current knowledge about
delirium is mostly based on individuals treated with SAVR
and those younger than 80.9,11 Individuals aged 80 and older
undergoing TAVI have a lower incidence of delirium than
those undergoing SAVR,12 although it is unclear whether
delirium after the less-invasive TAVI leads to equally adverse
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effects in terms of activities of daily living (ADLs), instrumen-
tal activities of daily living (IADLs), and cognitive function
when assessed 1 and 6 months after treatment.
Perception of health is important when longevity is
not a dominant priority.13 Measurement of self-reported
health status in elderly populations has been suggested as
being important,14 and quality of life after TAVI has been
studied to some extent,15,16 but little is known about how
delirium affects the self-reported health of individuals aged
80 and older after aortic valve implantation. The aim of
this study was therefore to determine how delirium could
predict ADL and IADL function, cognitive function, and
self-reported health status in individuals aged 80 and older
1 and 6 months after treatment with SAVR or TAVI.
METHODS
This was a prospective cohort study of individuals consec-
utively undergoing elective TAVI or SAVR in a tertiary
hospital in western Norway.
Study population
Individuals were recruited into the larger Delirium in
Octogenarians Undergoing Cardiac Surgery or Intervention
(CARDELIR) study.12 Inclusion criteria were aged 80 and
older, severe aortic stenosis, and elective treatment with
TAVI or SAVR. Exclusion criteria were inability to speak
and understand Norwegian or declined consent to partici-
pate. According to guidelines on management of valvular
heart diseases, severe aortic stenosis is defined as aortic
valve area of less than 0.6 cm2/m2, mean gradient of
greater than 40 mmHg, and maximum jet velocity of
greater than 4.0 m/s.17 A specialist heart team comprising
cardiothoracic surgeons and invasive cardiologists identified
individuals who were unsuitable for SAVR. Previous coro-
nary artery bypass graft, severe respiratory insufficiency,
comorbidities that could compromise recovery, calcified
ascending aorta, and prior thoracic radiotherapy were the
main reasons for being ineligible for treatment with SAVR.
From February 2011 until August 2013, 162 individuals
aged 80 and older were treated with SAVR or TAVI. Of
these, 15 failed to fulfill the inclusion criteria. The remaining
147 received study information, and 144 of these agreed to
participate, although data analyzed for this study included
those from only 136 individuals, because one withdrew con-
sent before treatment, and delirium was not established in
seven because they were nonresponsive or had died. An indi-
vidual was classified as having experienced delirium if delir-
ium was identified on at least 1 of the 5 postoperative days.
Individuals who were not tested for delirium because of
administrative or other reasons were classified according to
delirium status for the days that they were tested.
Measurements
Delirium
The Confusion Assessment Method (CAM), which identifies
delirium based on acute onset and fluctuating course, inatten-
tion, disorganized thinking, and altered level of conscious-
ness, was used to assess delirium.18 Delirium is diagnosed
when the first two features and the third or the fourth are pre-
sent.18 The psychometric properties of the CAM are good.19
Physical Function
Activities of Daily Living
The Barthel Index, which evaluates self-care abilities in
feeding, bathing, grooming, dressing, bowel, bladder, toilet
use, transferring, walking, and using stairs, was used as
one measure of activity level. The maximum score is 20,
and a score of at least 19 indicates functional indepen-
dence.20 When administered in an interview, the Barthel
Index has sufficient psychometric properties to provide a
valid measure ADLs.21
Instrumental Activities of Daily Living
The Nottingham Extended Activities of Daily Living Scale
uses 22 items to evaluate an individual’s ability to perform
complex levels of functioning, such as cooking, household
management, and use of public transportation. Each item
is scored from 0 to 3, and the items are summed, with 66
being the highest score. Higher scores indicate greater
levels of independence.22 This index is reliable and valid.23
Cognitive Function
Cognitive function was assessed using the Mini-Mental
State Examination (MMSE),24 which has a range of 0–30
points, with 30 indicating the best cognition. In the Nor-
wegian version, a score of 27 or less indicates poor cogni-
tive function. The MMSE is a valid instrument for
assessing global cognitive function.24
Self-Reported Health Status
Medical Outcomes Study 12-Item Short-Form Health
Survey
The Medical Outcomes Study 12-Item Short-Form Health
Survey (SF-12) was used to measure subjective general
health.25 It is a generic, self-assessed health index based on
12 items and is combined into two summary scores: the
Physical Component Summary (PCS) and the Mental Com-
ponent Summary (MCS). Scores range from 0 to 100, with
higher scores indicating better self-reported health status.
The psychometric properties of the SF-12 are good.25
Other Study Variables
Comorbidity
The Charlson Comorbidity Index, which predicts mortality
in individuals with comorbid disorders, was used to quan-
tify comorbidities.26 It has been shown to have good psy-
chometric properties.26,27
Cardiac Operative Risk
The Logistic European System for Cardiac Operative Risk
Evaluation I (Logistic EuroSCORE I), which uses a scoring
system that calculates operative mortality for individuals
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undergoing cardiac surgery, was used to evaluate mortality
risk.28 The Logistic EuroSCORE I takes into consideration
17 risk variables that predict mortality. Higher scores indi-
cate greater operative mortality risk.29
The selection of explanatory variables included in the
prediction models for the present study was based on pre-
vious research exploring the consequences of delirium after
cardiac surgery,9,11,30,31 taking into account clinical expe-
rience and the limited sample size.
Data Collection
Preoperative Data and Postoperative Assessment of
Delirium
A detailed description of preoperative data collection and
assessment of delirium was presented in a previous arti-
cle.12 Briefly, the day before treatment, ADL and cognitive
function were evaluated in individuals fulfilling the inclu-
sion criteria. A self-report form containing IADL and
SF-12 questionnaires was given to participants at the end
of the inclusion process and collected before surgery.
Demographic and clinical data were gathered from medical
records or in an interview, as appropriate.
The presence of delirium was measured daily, includ-
ing weekends, at approximately noon from Postoperative
Day 1–5. Research nurses trained in CAM performed clini-
cal assessments at participants’ bedsides. Medical, nursing,
and physiotherapist reports from the previous 24 hours
and meetings with health professionals in charge of the
participants were taken into consideration when scoring
the CAM.
One- and 6-Month Assessments
Follow-up visits were scheduled at the hospital 1 and
6 months after treatment. Information about ADL func-
tion was collected at this time, and self-report forms con-
taining IADL and SF-12 questionnaires were provided. If a
participant was unable to attend a follow-up visit, and a
new appointment could not be scheduled within a window
of 2 weeks, telephone contact was attempted. Information
required for the Barthel Index was collected over the tele-
phone, and then self-report forms containing IADL and
SF-12 questionnaires were mailed for completion at home.
The MMSE was administered after 6 months in partici-
pants attending follow-up visits.
Data Analyses
Data are presented as counts and percentages or means
and standard deviations or confidence intervals. Longitudi-
nal linear models were fitted separately, with time, delir-
ium, and the interaction between time and delirium as
explanatory factors to estimate mean ADL, IADL, MMSE,
SF-12 PCS, and SF-12 MCS scores at baseline and 1- and
6-month follow-up. To estimate how delirium could
improve predictions over baseline scores alone or baseline
scores and other risk or comorbidity factors, linear longi-
tudinal models for the scores were fitted at 1- and 6-month
follow-up using baseline score as an explanatory variable
for the unadjusted analysis and baseline score, sex,
Charlson Comorbidity Index, and logistic EuroSCORE I
as explanatory variables for the adjusted analysis.
All longitudinal models were fitted separately for
each treatment (SAVR, TAVI) using generalized least
squares with an unstructured correlation matrix. P ≤ .05
was considered statistically significant. Reported P-values
were not adjusted for multiple comparisons. Data man-
agement and initial statistical analyses were conducted
using SPSS version 22.0 (IBM SPSS Statistics for Win-
dows, Armonk, NY) and R 3.1.1 (R Foundation for Sta-
tistical Computing, Vienna, Austria) was used for all
reported statistical analyses except those reported in
Table 1. The R package “nlme” was used for longitudi-
nal analyses.
Missing Data
Data were screened and checked for missing units (ques-
tionnaires) and loss of single items.32 Before data collec-
tion started, a coding system for missing data was
implemented (participant did not answer item, participant
withdrew from study, participant died). Participants with
incomplete baseline SF-12 units were more likely to be
male (P = .02). Otherwise, no differences were found at
baseline or follow-up in terms of sex, comorbidity, or mar-
ital or educational status between participants with com-
plete and incomplete units.
By the time data collection ended, 22 participants
were lost-to-follow-up, nine of whom had withdrawn
from the study (8 treated with SAVR) and 13 of whom
had died (8 treated with TAVI). Including participants
who were lost to follow-up, cognitive screening
6 months after treatment was not performed in 45
(31%). Twenty-two of these participants did not attend
6-month follow-up at the hospital. The majority of these
nonattendees were living more than 2 hours away from
the hospital; five said that the hospital was too far away
from their residence to attend the consultation, nine that
they were not well enough to travel, and four that they
were healthy and did not need further follow-up exami-
nation; three did not indicate their reason for not
attending the follow-up; and two could not be con-
tacted. Participants who did not attend their 6-month
follow-up visit did not differ from those attending in
terms of sex (P = .27), baseline comorbidities (P = .74),
or baseline MMSE score (P = .83).
Handling of Missing Data
Because it could not be assumed that data were missing
completely at random, a likelihood-based longitudinal
model, requiring only the much weaker missing at random
assumption, was used. Still, there could be informative
censoring that the model did not capture, with, for exam-
ple, participants showing greater improvements from base-
line being more likely to respond to the follow-up
questionnaire. A sensitivity analysis for the changes from
baseline was therefore performed in which all missing data
were replaced with participants’ baseline values and the
statistical analysis repeated. The results from the sensitivity
analysis can be seen in Figure S1.
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Ethical Considerations
This study was conducted in accordance with the Declara-
tion of Helsinki and approved by the Regional Committee
for Ethics in Medical Research in Norway (REK Vest
2010/2936–6). Special consideration was given to signs of
participant exhaustion during data collection. Whenever
these signs were present, data collection was stopped and
later resumed.
RESULTS
Characteristics of the Study Population
Clinical and sociodemographic characteristics of included
participants are presented in Table 1. Fifty-seven percent
of the participants were female, and TAVI was performed
in 46% of the study population. Participants in the TAVI
group were older (P < .001) and had more comorbidities
(P < .001), a higher Logistic EuroSCORE I (P < .001),
poorer IADL function (P < .001), lower MMSE scores
(P = .007), lower SF-12 PCS scores (P = .002), and lower
SF-12 MCS scores (P = .09).
Participants without delirium were not different from
those with delirium in terms of sex (P > .14), comorbidity
index (P > .20), or logistic EuroSCORE (P > .31), but par-
ticipants treated using SAVR developed delirium more
often than participants treated with TAVI (P = .01).
Postoperative Delirium
An earlier article12 presented the incidence of delirium in
the studied population. Delirium was identified in 66% of
participants in the SAVR group and 44% of those in the
TAVI group.12
ADLs–SAVR Group
ADL scores of participants treated with SAVR were simi-
lar to baseline scores at 1- and 6-month follow-up regard-
less of the presence of delirium (all P > .05) (Figure 1).
Delirium did not predict performance well when adjusted
for baseline or baseline and other risk factors (Table 2).
ADLs–TAVI Group
At 1-month follow-up, participants in the TAVI group
with delirium had much worse mean ADL scores than at
baseline. After 6 months, ADL scores for the TAVI group
with delirium had improved and were no longer statisti-
cally significantly different from baseline scores (P = .06).
The 1- and 6-month follow-up scores of participants
undergoing TAVI who did not develop delirium were simi-
lar to their baseline scores (Figure 1). The regression
models showed that delirium predicted performance well
at 1-month follow-up, even when baseline ADL function
was included as a linear predictor in the models (Table 2).
Table 1. Characteristics of Individuals Aged 80 and Older Undergoing Transcatheter Aortic Valve Implantation















Age, mean  SD 83.5  2.7 81.6  1.4 82.7  2.3 .01 84.7  2.8 84.9  2.8 .74
Female, n (%) 76 (56) 12 (48) 24 (50) .87 25 (71) 15 (54) .14
Married, n (%) 73 (54) 16 (64) 27 (56) .52 15 (43) 15 (54) .40
Activity of daily living function, mean  SD
(range 0–20)
18.9  1.5 19.5  1.0 18.9  1.5 .06 18.9  1.5 18.5  1.4 .28
Instrumental activity of daily living function,
mean  SD (range 0–66)
54.2  10.1 57.1  8.7 57.5  7.9 .87 52.4  10.9 48.6  11.1 .21
Mini-Mental State Examination score, mean  SD
(range 0–30)
27.2  2.9 27.9  2.2 27.8  2.8 .86 27.4  2.4 25.4  3.6 .01
Medical Outcomes Study 12-Item Short Form Survey score, mean  SD (range 0–100)
Physical Component Summary 33.9  10.6 38.4  8.8 36.2  10.4 .40 30.5  10.0 30.9  11.3 .88
Mental Component Summary 48.7  10.8 50.3  10.6 50.1  10.4 .94 47.0  8.3 47.1  14.1 .95
Charlson Comorbidity Index, mean  SD 2.1  1.2 1.8  1.0 1.8  0.9 .78 2.3  1.3 2.7  1.3 .20
Logistic European System for Cardiac Operative Risk
Evaluation I, mean  SDa
14.0  9.2 9.9  3.8 8.8  3.1 .31 19.4  1.0 19.8  11.6 .86
New York Heart Association class
I + II 47 (35) 13 (54) 24 (54) .98 6 (19) 4 (18) .96
III + IV 75 (55) 11 (46) 20 (45) .98 26 (81) 18 (81) .96
Left ventricular ejection fraction, % 56.6  10.2 57.2  12.0 57.3  9.4 .97 55.9  10.4 55.6  10.3 .89
Maximum aortic gradient, mmHg 79.5  23.9 86.2  26.7 82.1  23.8 .54 73.4  23.7 76.9  20.9 .54
Mean aortic gradient, mmHg 48.3  16.1 51.6  16.8 50.1  16.2 .72 45.6  16.0 45.9  15.2 .93
Aortic valve area, cm2/m2 0.4  0.2 0.4  0.1 0.4  0.2 .29 0.4  0.1 0.4  0.07 .40
American Society of Anesthesiologists classification, n (%)
3 114 (84) 25 (100) 46 (96) .30 23 (66) 20 (71) .63
4 22 (16) 0 (0) 2 (4) .30 12 (34) 8 (29) .63
SD = standard deviation.
aP-value based on log-transformed values.
JAGS JUNE 2016–VOL. 64, NO. 6 DELIRIUM IN OCTOGENARIANS AFTER TAVI OR SAVR 1181
This analysis also showed that participants who developed
delirium had mean baseline-adjusted scores 3.1 points
lower (worse) than those who did not (P = .002). This
effect also persisted when adjusting for other risk and
comorbidity factors (sex, Charlson Comorbidity Index,
baseline logistic EuroSCORE I) (P = .001). At 6-month
follow-up, presence of delirium in the first 5 days after
surgery no longer predicted ADL performance.
IADLs–SAVR Group
IADL scores at 1-month follow-up were lower than at
baseline for participants who did not develop delirium
(P = .02) and even lower for those who did (P < .001).
There were no or minor differences from baseline at 6-
month follow-up (P = .50 for participants without delir-
ium, P = .05 for SAVR participants with delirium). The
Figure 1. Model-based estimated means for activities of daily living (ADLs; possible range of scores 0–20), instrumental activities
of daily living (IADLs; possible range of scores 0–66), Mini-Mental State Examination (MMSE; possible range of scores 0–30),
and Medical Outcomes Study 12-item Short Form Survey scores ((SF-12) possible range of scores 0–100) (with 95% confidence
intervals) at baseline and 1- and 6-month follow-up. Organized according to treatment (surgical aortic valve replacement
(SAVR), transcatheter aortic valve implantation (TAVI)) and presence or absence of delirium (circles and triangles, respectively)
(N = 136). The result of testing for change from baseline, based on longitudinal models, is shown as P-values at each time point.
See Table 2 for information on the number of observations used to estimate each outcome.
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regression models showed no predictive power of delirium
at 6 months but suggest a possible moderate to large effect
size at 1 month (not statistically significant) (Table 2).
IADLs–TAVI Group
At 1-month follow-up, IADL scores did not differ from
baseline in participants who did not develop delirium
(P = .60) but were lower than at baseline for those who
did (P = .003). There were no differences in scores from
baseline to 6-month follow-up independent of delirium
(without delirium, P = .60; with delirium, P = .40) (Fig-
ure 1). The regression models showed that, for participants
undergoing TAVI, delirium predicted performance well at
1-month follow-up, even after adjusting for baseline IADL
function. According to this analysis, participants who
developed delirium had mean baseline-adjusted scores that
were approximately 10 points lower (worse) than scores of
those who did not (P = .005). This was also the case when
adjusted for other risk and comorbidity factors (Table 2).
MMSE–SAVR Group
There were no differences in cognitive function between
baseline and 6-month follow-up in participants who did
and did not develop delirium (Figure 1). For participants
undergoing SAVR, the regression models showed no signif-
icant improvement in prediction when including delirium
as a predictor in the analysis (Table 2).
MMSE–TAVI Group
Although individuals undergoing TAVI who developed
delirium had lower overall scores than those who did
not (even at baseline), no differences in cognitive
function were found 6 months after treatment (Table 2).
Taking into account baseline MMSE score and other
risk factors, including information on the presence or
absence of delirium did not improve predictions
(Table 2).
SF-12 PCS–SAVR Group
There were minor, statistically nonsignificant changes in
SF-12 PCS score after 1 month. Participants who did
and did not develop delirium had a major increase in
scores at 6-month follow-up (P ≤ .007) (Figure 1). The
regression models found no improvements in prediction
when taking the presence of delirium into account,
except for a significant (P = .05) effect after 6 months
(Table 2).
SF-12 PCS–TAVI Group
At 1-month follow-up, only participants who did not
develop delirium had a statistically significant improve-
ment in self-reported physical health (P = .04). Six months
later, there were improvements in all participants (Fig-
ure 1). The regression models showed no improvement in
prediction when taking the presence of delirium into
account (Table 2).
SF-12 MCS–SAVR Group
There were no statistically significant differences on the
SF-12 MCS at 1- or 6-month follow-up (Figure 1). The
regression model revealed no improvement in prediction
when taking the presence of delirium into account
(Table 2).
Table 2. Effect of Experiencing Delirium on Physical and Cognitive Function and Self-Reported Health, Adjusted
for Baseline Values, at 1- and 6-Month Follow-Up, for Individuals Aged 80 and Older with Severe Aortic Stenosis
Assessment



















Activity of daily living function 67 0.3, .60 0.1, .90 0.0, >.99 0.3, .70 60 3.1, .002 1.5, .10 3.1, .001 1.6, .10
Instrumental activity of daily living
function
47 8.1, .07 1.8, .70 9.4, .06 3.0, .60 48 10.6, .004 3.0, .40 10.5, .005 2.3, .50
Mini-Mental State Examination 45 0.3, .70 0.6, .50 52 1.1, .40 1.4, .20
Medical Outcomes Study 12-Item Short Form Survey
Physical Component Summary 52 2.9, .20 4.1, .10 4.0, .10 4.9, .05 44 0.6, .80 0.9, .80 0.6, .80 1.1, .70
Mental Component Summary 52 5.1, .10 5.1, .10 6.3, .06 4.3, .20 44 4.0, .20 2.4, .40 3.6, .20 3.0, .30
aAdjusted for baseline score.
bAdjusted for sex and baseline score, Charlson Comorbidity Index, and Logistic European System for Cardiac Operative Risk Evaluation I.
cEstimated difference in mean score between an individual experiencing delirium and an individual not experiencing delirium based on a linear longitudinal
model with the mean score of the individual experiencing delirium modeled as a linear function of experiencing delirium and baseline value/baseline value
and other risk factors.
*Number of patients included in the models, i.e., with at least one measurement (baseline, 1 month and/or 6 month).
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SF-12 MCS–TAVI Group
No statistically significant changes were found in partici-
pants who did or did not develop delirium at 1- or 6-
month follow-up (Figure 1). For participants undergoing
TAVI, there was no effect of delirium at 1- or at 6-month
follow-up (Table 2).
Sensitivity Analysis
The results from the sensitivity analysis showed only minor
changes in the estimated effects, so the findings seem
robust. All changes from baseline with P ≤ .04 (in Fig-
ure 1) remained statistically significant. The results from
the sensitivity analysis are presented in Figure S1. This
supplement is organized like Figure 1, but all estimates
and P-values are based on the sensitivity analysis model
described.
DISCUSSION
To the best of the knowledge of the authors, this is the
first study to examine delirium as a predictor of ADL,
IADL, and cognitive function and self-reported health in
individuals aged 80 and older after TAVI. This work
demonstrates how delirium affects individuals aged 80 and
older after SAVR or TAVI, the latter being a less-invasive
treatment.
Previous studies found an association between delir-
ium and functional decline after hip fracture8 and cardiac
surgery.9,11 It has been suggested that functional impair-
ment is an important end point after cardiac surgery in
older adults.33,34 The current study shows that, at 1-month
follow-up, participants who underwent TAVI and devel-
oped delirium had a major decrease in ADL scores. This
effect persisted after adjusting for baseline ADL score and
other risk factors. The same level of decrease was not pre-
sent in individuals aged 80 and older undergoing the
more-invasive SAVR. One could argue that individuals
aged 80 and older scheduled for TAVI are more vulnerable
than those undergoing SAVR. ADL scores in participants
undergoing TAVI and not developing delirium remained
constant from baseline to follow-up.
IADL function has been linked to cognition.35 In the
current study, participants with delirium scored lower on
the IADL scale at 1-month follow-up than those without
delirium: 16 points for participants undergoing SAVR and
9 points for participants undergoing TAVI. Diminished
IADL performance might be expected, especially after
SAVR, which requires full sternotomy, aortic cross-clamp-
ing, and extracorporeal bypass circulation. Furthermore,
electrocardiography devices, temporal pacemakers, and
catheters limit mobility during the immediate postoperative
period. After 6 months, the IADL scores of individuals
who underwent TAVI and SAVR had increased and did
not significantly differ from baseline.
Important differences in cognitive function were iden-
tified. MMSE scores at baseline and 6-month follow-up of
individuals who underwent TAVI and developed delirium
were approximately 2 points lower than scores of partici-
pants undergoing TAVI who did not develop delirium,
although the cognitive changes from baseline to 6-month
follow-up in all participants treated with TAVI were not
significant. No differences were observed in MMSE scores
of participants who underwent SAVR, regardless of devel-
opment of delirium. Even though diminished cognitive
function has been reported 6 months after hip fracture in
individuals with delirium,36 and delirium has been shown
to be associated with persistent cognitive impairment and
prolonged recovery up to 1 year after cardiac surgery,31 a
decrease in cognitive scores 6 months after SAVR or TAVI
was not observed. These encouraging results compare
favorably with findings from other studies30 and provide
further knowledge in the area of delirium by including
individuals undergoing cardiac surgery aged 80 and older
treated with a novel aortic valve therapy. The study mea-
sured cognitive function only at baseline and 6-month fol-
low-up, and it was not possible to explore possible
fluctuations that could have occurred during the intermedi-
ate postoperative period. It also cannot be determined
whether some participants developed cognitive impairment
after 6 months.
The SF-12 has been used to measure self-reported
health status after SAVR and TAVI.37–39 To the authors’
knowledge, the self-reported health of individuals aged 80
and older undergoing TAVI who develop delirium has not
been established. The PCS score of individuals who under-
went SAVR and developed delirium was lower (nonsignifi-
cantly) at 1-month follow-up than at baseline but
improved significantly at 6 months. The scores of individu-
als who underwent SAVR and did not develop delirium
remained constant at 1-month follow-up and improved
greatly after 6 months, supporting observations from the
Placement of AoRTic TraNscathetER Valve Trial.39 In the
current study, participants treated with TAVI had the low-
est PCS scores at baseline. Differences in scores between
the TAVI and SAVR groups became more accentuated
6 months after treatment, suggesting that individuals who
underwent TAVI were frail at baseline and remained frail
after treatment.
MCS scores of the SAVR and TAVI groups had a dif-
ferent pattern than others have reported.37,39 There was
no statistically significant difference in these scores from
baseline to 1- and 6-month follow-up. The utility of the
SF-12 for detecting changes over time in individuals with
heart failure has been questioned.40 Similarly, the SF-12
MCS may not be sufficiently sensitive to detect changes in
delirium. It is also possible that participants in the SAVR
group had higher expectations for the procedure than the
frailer group that underwent TAVI and developed delir-
ium. Nevertheless, it is surprising that cognitive, ADL, and
IADL function were well preserved in the SAVR cohort,
because these participants did not receive as much screen-
ing as those in the TAVI group regarding general
atherosclerosis and aortic calcification. This indicates that
the selection and quality of surgery and perioperative
treatment of participants were good, because participants
who underwent TAVI were older and had a higher Euro-
SCORE and more comorbidities. It also shows that SAVR
may be performed safely in individuals aged 80 and older
with reasonably good physical and mental health. With
new technology (widespread use of intraoperative, epiaor-
tic ultrasound to detect aortic atheroma and thereby avoid
cerebral embolization; recently developed rapid
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deployment aortic valve prostheses to reduce extracorpo-
real bypass circulation time in elderly adults undergoing
open surgery for aortic stenosis), SAVR may potentially be
performed with even less risk of cerebral complica-
tions.41,42
This study has several strengths, including its
prospective design with consecutive inclusion of individu-
als and its use of valid and reliable instruments. Further-
more, the study hospital performs all TAVI and SAVR
in western Norway, allowing the inclusion of a represen-
tative group of individuals aged 80 and older with sev-
ere aortic stenosis from the entire region. The fact that
the participants were more homogeneous in terms of
age, diagnosis, and treatment received than in other
studies9,11,30,31 can explain the high incidence of delir-
ium in the current study. Screening with CAM was per-
formed in a thorough manner at bedside for 5 days
postoperatively, starting on the first postoperative day.
Participants were also assessed on weekends and holi-
days. Meetings with health professionals in contact with
participants and close examination of their reports were
performed before the CAM was scored.
A limitation of the study is that it was not designed
as a randomized controlled trial. Randomization to com-
pare treatment modalities was not possible, because
TAVI and SAVR are used to treat distinctly different
target groups.6 Because of this, the results were analyzed
stratified according to treatment. Another limitation was
the modest size of the studied cohort. The results war-
rant future studies with larger samples. There was also
the risk of type 1 errors due to use of multiple testing.
The high ADL, IADL, and cognitive functioning of the
cohort may limit the applicability of the results to other
populations and might indicate that subject selection bias
was present before participants were referred to the uni-
versity hospital. It is also a limitation that cognitive
function at 6-month follow-up was not measured in the
22 participants who did not attend their consultation,
but the consequences of missing MMSE data at
6 months were investigated in a sensitivity analysis and
showed only minor changes in the estimated effects.
Other tools could have been added to complement the
cognitive evaluation done with the MMSE.43 Six months
may be considered a short follow-up period for evaluat-
ing the long-term consequences of delirium. This war-
rants further study with longer follow-up.
In conclusion, delirium is an important predictor of
lower ADL and IADL function 1 month after invasive
treatment for aortic stenosis, even when gentler tech-
niques such as TAVI are used. Lower ADL and IADL
scores at 1-month follow-up (Figure 1) in individuals
aged 80 and older with postoperative delirium address
the importance of prevention and recognition of the con-
dition. This is probably even more relevant in a popula-
tion in which functional ability is perhaps more
appealing than longevity. Close monitoring of individuals
at risk of developing delirium, even after less invasive
aortic valve therapy, is therefore recommend. Future
studies should focus on the effect of delirium on adverse
events demanding acute readmission to hospital and
nursing home placement in individuals aged 80 and
older after SAVR or TAVI.
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